Literature DB >> 30605960

[Guideline on the assessment and management of cardiovascular risk in China].

.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death and burden of diseases in China. Prevention and control of CVD has been challenging. Risk assessment and management for CVD risk factors are essential for primary prevention of CVD. According to recent observational and interventional evidences worldwide and studies in Chinese population, the guideline introduced how to conduct cardiovascular risk assessment in China, including the procedure for 10-year and lifetime risk assessment, the risk stratification, and the application of web-based and mobile risk assessment tools. Furthermore, in order to facilitate the primary prevention of CVD, the guideline targeted therapeutic lifestyle changes, and highlighted principles for management of blood pressure, lipids, and glucose, etc. The implementation of the guideline will facilitate the risk assessment of CVD and risk factor management, and promote both individualized and community-based prevention of CVD in China.

Entities:  

Keywords:  Cardiovascular diseases; Guideline; Primary prevention; Risk assessment

Mesh:

Year:  2019        PMID: 30605960     DOI: 10.3760/cma.j.issn.0253-9624.2019.01.004

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  16 in total

1.  Hypertension modifies the associations of body mass index and waist circumference with all-cause mortality among older Chinese: a retrospective cohort study.

Authors:  Kaizhi Bai; Xuejiao Chen; Zhan Shi; Kun He; Xueqi Hu; Rui Song; Wenlong Shi; Qingfeng Tian; Songhe Shi
Journal:  BMC Geriatr       Date:  2022-05-19       Impact factor: 4.070

Review 2.  Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Li Li; Sang-Hoon Na; Francesca Santilli; Zhongwei Shi; Michael Blaha
Journal:  Am J Prev Cardiol       Date:  2022-06-06

3.  Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank.

Authors:  Songchun Yang; Yuting Han; Canqing Yu; Yu Guo; Yuanjie Pang; Dianjianyi Sun; Pei Pei; Ling Yang; Yiping Chen; Huaidong Du; Hao Wang; M Sofia Massa; Derrick Bennett; Robert Clarke; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Neurology       Date:  2022-04-11       Impact factor: 11.800

4.  2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Zhong-Wei Shi; Dong Zhao; Da-Wei Yin
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

5.  Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes.

Authors:  Yongdi Wang; Jian Wang
Journal:  Diabetol Metab Syndr       Date:  2022-01-28       Impact factor: 3.320

6.  Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China.

Authors:  Yunxing Jiang; Xianghui Zhang; Rulin Ma; Xinping Wang; Jiaming Liu; Mulatibieke Keerman; Yizhong Yan; Jiaolong Ma; Yanpeng Song; Jingyu Zhang; Jia He; Shuxia Guo; Heng Guo
Journal:  Clin Epidemiol       Date:  2021-06-09       Impact factor: 4.790

7.  Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study.

Authors:  Dong-Feng Wu; Yin-Xiong Wu; Jin-Long Deng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 8.  Clinical applications for out-of-office blood pressure monitoring.

Authors:  Hailan Zhu; Haoxiao Zheng; Xinyue Liu; Weiyi Mai; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2020-01-20       Impact factor: 5.091

9.  Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease.

Authors:  Wen Hu; Ziyu Liu; Weinan Yu; Surong Wen; Xiaoqing Wang; Xing Qi; Hairong Hao; Yanwen Lu; Jing Li; Shayan Li; Hongwen Zhou
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China.

Authors:  Jianxin Li; Fangchao Liu; Xueli Yang; Jie Cao; Shufeng Chen; Jichun Chen; Keyong Huang; Chong Shen; Xiaoqing Liu; Ling Yu; Yingxin Zhao; Xianping Wu; Liancheng Zhao; Xigui Wu; Ying Li; Dongsheng Hu; Jianfeng Huang; Xiangfeng Lu
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.